An open label, single-dose, randomized crossover study assessing absolute bioavailability of the active triazole, isavuconazole in healthy male volunteers.

Trial Profile

An open label, single-dose, randomized crossover study assessing absolute bioavailability of the active triazole, isavuconazole in healthy male volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Jul 2016

At a glance

  • Drugs Isavuconazole (Primary) ; Isavuconazole (Primary)
  • Indications Mycoses
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 Jul 2016 New trial record
    • 27 Jun 2016 Results from EudraCT 2007-004949-15, EudraCT 2007- 004940-63 and NCT02128893 trials published in the International Journal of Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top